⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

AI Visibility Scorecard

Current research for HDAC inhibitors in pancreatic cancer

Current research for HDAC inhibitors in pancreatic cancer

Unclaimed

techbizstrategy.com · Healthcare

Borderline visible. AI bots can crawl Current research for HDAC inhibitors in pancreatic cancer, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

AI engines read this profile 5 times

Claude · Meta AI · Apple Intelligence

#486,678 of 875,407 in Healthcare for AI visibility

5

AEO Visibility

i

Borderline · 4.5/10

5

Muse Index Score

i

AI agent readiness

Basic · 5/100

4

AI Adoption

i

Basic · 4/100

Share

About Current research for HDAC inhibitors in pancreatic cancer

from our crawl and measurement

Current research for HDAC inhibitors in pancreatic cancer describes itself simply: "yet recently been reported in in vitro models of cancer of the breast." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 4.5 out of 10.

Our crawl found a sitemap. It is missing structured data describing the business, an llms.txt file and a heading structure that lays out what it offers.

AI crawlers have visited 3 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).

Industry · Healthcare
Last scored · Aug 7, 2026

The 6 signals AI reads

Higher is better · 0-10

Structured Data

1

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

6

Clear headings and answer-style content.

Entity Clarity

3

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

3

Experience, Expertise, Authority, Trust markers.

Technical AEO

5

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

4

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

7

Inbound links from other sites.

Domain Authority

0

Little domain authority yet.

Reference Presence

0

Not in AI knowledge graphs yet.

News & Press

0

No press coverage found yet.

Community

1

Forum and community discussion.

Social Mentions

0

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4.5/10, Current research for HDAC inhibitors in pancreatic cancer is crawlable but under-signaled - fixable, and the signals above are where to start.

Is this your brand?

The exact fixes for Current research for HDAC inhibitors in pancreatic cancer

Which AI engines already crawl you

Free AI bot monitoring: see every AI crawler that visits you

Already have an account? Sign in

Picked for Current research for HDAC inhibitors in pancreatic cancer: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Current research for HDAC inhibitors in pancreatic cancer.

Source & Attribution

Scored by Engagemii on August 7, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/techbizstrategy

Cite this score: Engagemii (2026). "AEO Score for Current research for HDAC inhibitors in pancreatic cancer." Retrieved from https://engagemii.com/aeo/brands/techbizstrategy

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform